北京五和博澳药业股份有限公司成立于2010年，是集研发、生产、销售一体 的创新型医药企业，系国家高新技术企业、中关村重大前沿原创高精尖企业、北京 市“专精特新”企业、北京市企业技术中心、国家知识产权优势企业。公司避开化 药仿制及生物药的模仿式创新等传统赛道，重点发展“现代天然药物”及“高端创 新制剂”，聚焦代谢性疾病、恶性肿瘤、抗炎免疫等重大疾病领域，专注于具有自 主知识产权、高技术壁垒的原创新药，致力打造具有国际影响力的中国品牌。与国 家级科研院所深度产学研融合，构建多学科合作研发体系，由联合创新走向自主创 新，培育了系列新药产品线。研制的“桑枝总生物碱片”成为全球首个植物来源有效组分降血糖天然药物。

 Founded in 2010 and located in China Medicine Valley - Beijing Daxing  Biomedical Industry Base, Beijing Wehand-Bio Pharmaceutical Co., Ltd. is a national  high-tech enterprise, a major frontier original high-tech enterprise in Zhongguancun  Science Park, and a "Specialized, Excellent, Featured and Innovative" enterprise  in Beijing. Wehand-Bio mainly develops "modern natural medicine" and "high-end  innovative preparations" and focuses on the clinical treatment of metabolic diseases,  malignant tumors, anti-inflammatory and autoimmune diseases. Wehand-Bio has  been targeting at the development of original and globally exclusive innovative drugs  with independent intellectual property.

地址：北京市中关村科技园区大兴生物医药产业基地天富大街30号

No.30 TianfuStreet, Daxing Biomedicine Indusry Base,

Zhongguancun Science Park, China

电话：86-010-89285107